Heart Failure: Difference between revisions

No edit summary
(page link update)
 
(15 intermediate revisions by 3 users not shown)
Line 5: Line 5:
</div>
</div>


== Definition/Description  ==
== Introduction ==
[[File:Human-heart-chambers.jpg|right|frameless]]
[[File:Heart failure.png|right|frameless|457x457px]]
Heart failure is a term used to cover three distinctive clinical presentations. The human heart has four chambers (two atria and two ventricles). In a normal heart, there are open connections between the right atrium and right ventricle through the tricuspid valve and also between the left atrium and left ventricle through the mitral valve. There are no open connections between the two atria and the two ventricles. Therefore, the left and right halves of the heart actually function as two hearts.  
[[Anatomy of the Human Heart|Heart]] failure is a syndrome of cardiac ventricular dysfunction, where the heart is unable to pump sufficiently to meet the body's [[Blood Physiology|blood]] flow requirements.


* The failure of the left half causes a distinct set of symptoms and signs which is called left heart failure.  
* The symptoms come from an inadequate cardiac output, failing to keep up with the metabolic demands of the body.
* The failure of the right half causes a distinct set of features collectively called right heart failure.  
* It is a leading cause of cardiovascular morbidity and mortality worldwide despite the advances in therapies and prevention.
* The combination of the two is known as congestive heart failure.  
* It can result from disorders of the pericardium, myocardium, endocardium, heart valves, great vessels, or some metabolic abnormalities.<ref name=":3">Hajouli S, Ludhwani D. [https://www.ncbi.nlm.nih.gov/books/NBK553115/ Heart failure and ejection fraction.]Available: https://www.ncbi.nlm.nih.gov/books/NBK553115/<nowiki/>(accessed 19.9.2021)</ref>


It is important to understand that congestive heart failure is a type of heart failure and not a totally different condition<ref name=":2">Diffence between  Difference Between Heart Failure and Congestive Heart Failure Available:https://www.differencebetween.com/difference-between-heart-failure-and-vs-congestive%C2%A0heart-failure/ (accessed 1.6.2021)</ref>.
Heart failure is a major public health concern in [[Global Health|countries worldwide]].  The increasing prevalence of heart failure in the population is most likely secondary to the aging of the population, increased risk factors, better outcomes for [[Acute Coronary Syndrome|acute coronary syndrome]] survivors, and a reduction in mortality from other [[Chronic Disease|chronic conditions]]<ref>King KC, Goldstein S. [https://www.statpearls.com/ArticleLibrary/viewarticle/19880 Congestive Heart Failure and Pulmonary Edema]. StatPearls [Internet]. 2021 Jan 20.Available: https://www.statpearls.com/ArticleLibrary/viewarticle/19880<nowiki/>(accessed 2.6.2021)</ref>. It is estimated that globally more than 25 million people are affected by HF.<ref name=":1">Britannica [https://www.britannica.com/science/heart-failure Heart Failure] Available: https://www.britannica.com/science/heart-failure<nowiki/>(accessed 1.6.2021)</ref>
== Epidemiology ==
[[Image:Hf.png|right|frameless|620x620px]]
Heart failure is a significant public health problem with a prevalence of over 5.8 to 6.5 million in the U.S. and around 26 million worldwide<ref name=":0">Hajouli S, Ludhwani D. [https://www.ncbi.nlm.nih.gov/books/NBK553115/ Heart Failure And Ejection Fraction] 2020.Available from:https://www.ncbi.nlm.nih.gov/books/NBK553115/ (last accessed 11.8.2020)</ref>.


Heart failure is a major public health concern in countries worldwide. Although reliable data on the prevalence of heart failure is lacking for some parts of the world, it is estimated that globally more than 25 million people are affected by it.<ref name=":1">Britannica [https://www.britannica.com/science/heart-failure Heart Failure] Available: https://www.britannica.com/science/heart-failure<nowiki/>(accessed 1.6.2021)</ref><br>
Multiple conditions can cause HF, including systemic diseases, a wide range of cardiac conditions, and some hereditary defects.


== Causes ==
* Etiologies of HF vary between high-income and developing countries, and patients may have mixed etiologies.
Causes for heart failure can be many. There are three main pathologies that lead to heart failure; pump failure, increased pre-load, and increased after-load.  
**[[Coronary Artery Disease (CAD)|Coronary artery disease]] and chronic obstructive pulmonary disease ([[COPD (Chronic Obstructive Pulmonary Disease)|COPD]]) are the most common underlying causes of HF in high-income regions.
** Conversely, hypertensive heart disease, [[Rheumatic Heart Disease|rheumatic heart disease]], [[Cardiomyopathies|cardiomyopathy]], and myocarditis are the primary conditions for HF in low-income regions, according to a systemic analysis for the Global Burden of Disease Study.
* More than two-thirds of all cases of HF are attributable to ischemic heart disease, COPD, hypertensive heart disease, and rheumatic heart disease.<ref name=":3" />


# Pump failure can occur due to [[Myocardial Infarction|myocardial infarction]], [[Cardiomyopathies|cardiomyopathy]], poor heart rate (negative chronotropic drugs), poor contractility (negative inotropic drugs) and poor filling (restrictive pericarditis).
== Aetiology ==
# Preload may go up due to fluid overload, [[Aortic Valve Disease|aortic]] and pulmonary regurgitation.  
There are multiple risk factors for heart failure, including older age (65 years or over), being male, having a family history of the condition, or having certain underlying conditions, particularly [[Myocardial Infarction|myocardial infarction]] , cardiac valve insufficiency (leaking) or stenosis (narrowing), and [[diabetes]]. Certain lifestyle factors—such as tobacco smoking, [[Alcoholism|alcohol]] consumption, [[Physical Inactivity|physical inactivity]], and a diet that predisposes individuals to [[Hyperlipidemia|high cholesterol]] and high blood pressure—also raise the risk of developing heart failure<ref name=":1" />
# Afterload may go up due to excessively [[Hypertension|high systemic blood pressure,]] [[Aortic Valve Disease|aortic]] and pulmonary stenosis.<ref name=":2" />
== Types of HF ==
[[File:Heartfailure.jpg|right|frameless]]'''Left Ventricular Failure (LVF):''' the most common form of heart failure.
 
* Gradually pushes up the pressure in the left atrium and pulmonary vascular system.
* The resulting [[Pulmonary Hypertension|pulmonary hypertension]] may force fluid into the alveoli creating pulmonary oedema.
 
Therefore, the patient presents with dizziness, lethargy, poor exercise tolerance, syncope, fainting attacks, amaurosis fugax (due to poor output), dyspnea, orthopnea, paroxysmal nocturnal dyspnea and pink frothy sputum (due to increased pulmonary venous pressures)<ref name=":2" />.
 
'''Right Ventricle Failure (RVF)'''
 
* Image R: A depiction of heart enlargement during RVF, normal heart L, overstretched muscles heart R.
 
[[File:Right side heart failure.jpg|right|frameless]]Right heart failure causes poor pulmonary circulation and increased systemic venous pressures.  This generally occurs secondary to cardiopulmonary disorders such as [[Pulmonary Hypertension|pulmonary hypertension]], right ventricle infarction, [[Tetralogy of Fallot|congenital heart disease]], [[Pulmonary Embolism|pulmonary embolism]] or [[COPD (Chronic Obstructive Pulmonary Disease)|COPD]].<ref name="p3" />


Therefore, the patient presents with dependent edema, enlarged liver, elevated jugular venous pressure (due to increased systemic venous pressure), reduced exercise tolerance and dyspnea (due to poor pulmonary circulation).<ref name=":2" />
== Clinical presentation ==
Although it is useful to divide the signs and symptoms of heart failure according to the degree of left or right ventricular dysfunction, the heart is an integrated pump, and patients commonly present with both sets of signs and symptoms.  


'''Biventricular heart failure'''
Left ventricular failure: Patients usually report fatigue, [[Dyspnoea|dyspnea]] on exertion, and if severe, at rest. Orthopnea, paroxysmal nocturnal dyspnea and Cheyne-Stokes respiration can also be a feature.


Heart failure most typically occurs on the left side of the heart. When the damage expands and also impacts the right side it is referred to as biventricular heart failure. Symptoms can be reflective of both left and right-sided heart failure, including shortness of breath and swelling due to a build-up of fluid<ref>Health Union [https://heart-failure.net/left-right-biventricular/ Heart Failure] Available from: https://heart-failure.net/left-right-biventricular/ (last accessed 12.8.2020)</ref>
* On examination tachypnea, dyspnea, tachycardia, [[hypotension]] and cyanosis may be observed. Palpation may reveal a laterally displaced apex beat while cardiac auscultation may elicit murmurs such as aortic stenosis or mitral regurgitation. Features of [[Pulmonary Oedema|pulmonary edema]] eg inspiratory bibasal crackles not cleared on coughing, diminished [[Auscultation|breath sounds]] and dullness to percussion, may also be noted.


Right ventricular failure: Symptoms include [[Oedema Assessment|ankle swelling]], fatigue, abdominal bloating/discomfort and nocturia.


The 12 minute video below is on the classification of HF according to severity.{{#ev:youtube|YLjLFSdGxEU}}<ref>classification system of heart failure</ref>
* Evidence of right ventricular failure can manifest as peripheral edema (if severe extending to thighs and sacrum), ascites, hepatomegaly, elevated jugular venous pressure (JVP). JVP can be further accentuated by hepatojugular reflux. Cardiac murmurs may also be heard, commonly tricuspid regurgitation.


== Epidemiology  ==
Clinical severity varies significantly and usually classified according to the New York Heart Association, which is graded according to how much physical activity is decreased<ref name=":4" />.
[[Image:Hf.png|right|frameless|620x620px]]Heart failure is a significant public health problem with a prevalence of over 5.8 to 6.5 million in the U.S. and around 26 million worldwide<ref name=":0">Hajouli S, Ludhwani D. [https://www.ncbi.nlm.nih.gov/books/NBK553115/ Heart Failure And Ejection Fraction] 2020.Available from:https://www.ncbi.nlm.nih.gov/books/NBK553115/ (last accessed 11.8.2020)</ref>. HF is the world’s leading cause of hospitalization and results in a burden that is felt at every level of healthcare:


# For systems and healthcare workers assisting with greater numbers of very ill patients
== Pathology ==
# For health economies with increasing costs, particularly in a disease area where rehospitalizations are so high: 50% are readmitted within six months of discharge
[[File:Fig-2-Changes-in-the-myocardium-during-aging-Heart-and-vasculature-undergo-alterations.png|right|frameless|583x583px]]Myocardial damage due to [[Myocardial Infarction|myocardial infarcts]], [[Cardiomyopathies|cardiomyopathy]] and myocarditis can cause or aggravate heart failure.
# For patients who are diagnosed with a progressive disease without a cure, and their carers


The prognosis for those diagnosed with heart failure is poor:
Additionally, [[Cardiac Valve Defects|valvular disease]] such as aortic stenosis or mitral regurgitation may result in heart failure as well.


* 17-45% of patient deaths occur within one year of hospital admission
Further causes include conduction defects, [[Heart Arrhythmias: Assessment|cardiac arrhythmia]] and infiltrative/matrix disorders.
* 45-60% of deaths occur within five years of admission


But heart failure also takes its toll on people’s daily lives and their families, often resulting in a reduced ability to lead the same lifestyles as before.<ref>World heart federation [https://world-heart-federation.org/cvd-roadmaps/whf-global-roadmaps/heart-failure/ CVD road map] Available: https://world-heart-federation.org/cvd-roadmaps/whf-global-roadmaps/heart-failure/ (accessed 1.6.2021)</ref>
Systemic factors that may contribute or exacerbate heart failure include [[Anaemia|anemia]], [[hyperthyroidism]] or [[hypertension]]<ref name=":4">Radiopedia [https://radiopaedia.org/articles/heart-failure-summary?lang=us heart failure] Available: https://radiopaedia.org/articles/heart-failure-summary?lang=us<nowiki/>(accessed 19.9.2021)</ref>.


== Aetiology ==
See also [[Cardiovascular Considerations in the Older Patient]]
There are multiple risk factors for heart failure, including older age (65 years or over), being male, having a family history of the condition, or having certain underlying conditions, particularly [[Myocardial Infarction|myocardial infarction]] , cardiac valve insufficiency (leaking) or stenosis (narrowing), and [[diabetes]]. Certain lifestyle factors—such as tobacco smoking, [[Alcoholism|alcohol]] consumption, [[Physical Inactivity|physical inactivity]], and a diet that predisposes individuals to [[Hyperlipidemia|high cholesterol]] and high blood pressure—also raise the risk of developing heart failure<ref name=":1" />.
 
== Pathophysiology ==
[[File:Fig-2-Changes-in-the-myocardium-during-aging-Heart-and-vasculature-undergo-alterations.png|right|frameless|583x583px]]
The pathophysiology of HF is complex and includes structural, neurohumoral, cellular, and molecular mechanisms activation to maintain physiologic functioning (maladaptation, myocyte hypertrophy, myocyte death/apoptosis/regeneration, and remodeling).<ref name=":0" />
* In response to increased load, the left ventricular myocardium hypertrophies.
* The greater size and number of myocytes raise myocardial oxygen demand and increases diffusion distance for oxygen.
* Some muscle fibres become ischaemic, leading to patchy fibrosis, stiffness and reduced contractability<ref name="p1" />.
* The workload may cause the ventricle to stretch and dilate, leading to further force being required to maintain cardiac output<ref name="p1">Dickstein, K.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2008. Aug;10:933-989.</ref>.
* Systolic failure is by reduced ejection fraction and diastolic failure is by reduced end-diastolic volume.
* Metabolic effects include loss of bone mineralisation, skeletal muscle and fat<ref name="p3">Hough, A. Physiotherapy in Respiratory and Cardiac Care: An Evidence Based Approach. Hampshire. Cengage Learning EMEA; 2014.</ref>.
 
* The stiffness and reduced contractibility push up end-diastolic pressure, which is transmitted back along the pulmonary veins to the pulmonary capillaries, which causes fluid to be forced into the interstitial spaces and, if severe, into the alveoli, causing pulmonary oedema.
* The increased pulmonary vascular pressure raises the afterload of the right ventricle, in the same way as chronic systemic hypertension raises the afterload of the left ventricle<ref name="p2">British Society for Heart Failure. National Heart Failure Audit. London. November 2013.</ref>.
* Hypertrophy, patchy fibrosis, stiffness and reduced contractibility of the right ventricular myocardium then ensues, as with left ventricle, and congestive cardiac failure develops<ref name="p1" />.


== Management  ==
== Management  ==
[[File:Digoxin vial.jpg|right|frameless|496x496px]]
[[File:Digoxin vial.jpg|right|frameless|496x496px]]Prognosis is usually poor unless the underlying cause is reversed. As a result, patients generally gradually deteriorate with episodes of acute decompensation and ultimately death.
Treatment of heart failure is complex and multifaceted. Of prime importance is treatment of the specific underlying disease (such as hypertension, [[Cardiac Valve Defects|valvular heart disease]], or [[Coronary Artery Disease (CAD)|coronary heart disease]]). Prescribed medications are usually aimed at blocking the adverse effects of the various neurologic, [[Hormones|hormonal]], and inflammatory systems activated by heart failure.  


These are generally drugs in the class of [[ACE Inhibitors in the Treatment of Congestive Heart Failure|angiotensin-converting enzyme (ACE) inhibitors]] to lower blood pressure and decrease the heart’s workload, [[Beta-Blockers in the treatment of congestive heart failure|beta-adrenergic blockers]] (beta-blockers) to stabilize the heartbeat, aldosterone antagonists to decrease salt retention, and [[Vasodilators in the Treatment of Hypertension|vasodilators]] to relax the [[Muscle: Smooth|smooth-muscle]] lining of the veins and arteries. [[Diuretics|Diuretic]]<nowiki/>s are prescribed to remove excess fluid. [[Glycosides and Congestive Heart Failure|Digoxin and digitoxin]] are commonly prescribed to increase the strength of heart contraction<ref name=":1" />.
In addition to treating the underlying cause of heart failure, management is directed at dietary and lifestyle changes, medications including [[ACE Inhibitors: Congestive Heart Failure|ACE inhibitors]] or [[Beta-Blockers in the treatment of congestive heart failure|beta blockers]] and if appropriate, [[Cardiac Implantable Electronic Devices (CIEDs)|implantable cardioverter-defibrillator]] (ICD) or cardiac resynchronisation therapy (CRT).<ref name=":4" /> [[Diuretics|Diuretic]]<nowiki/>s are prescribed to remove excess fluid. [[Glycosides and Congestive Heart Failure|Digoxin and digitoxin]] are commonly prescribed to increase the strength of heart contraction<ref name=":1" />.


Patients are also advised to limit their intake of salt and fluids, avoid alcohol and nicotine, optimize their body weight, and engage in [[Aerobic Exercise|aerobic exercise]] as much as possible. Much can be done to prevent and treat heart failure, but ultimately the prognosis depends on the underlying disease causing the difficulty as well as the severity of the condition at the time of presentation.
Patients are also advised to limit their intake of salt and fluids, avoid alcohol and nicotine, optimize their body weight, and engage in [[Aerobic Exercise|aerobic exercise]] as much as possible. Much can be done to prevent and treat heart failure, but ultimately the prognosis depends on the underlying disease causing the difficulty as well as the severity of the condition at the time of presentation.


See also [[Pharmacological Management of Congestive Heart Failure|Pharmacological Management of Heart Failure]]
See also [[Congestive Heart Failure - Pharmacotherapy|Pharmacological Management of Heart Failure]]


=== Physiotherapy ===
=== Physiotherapy ===
Line 97: Line 71:
*Improve symptoms  
*Improve symptoms  
*Reduce the risk of a flare-up or worsening of symptoms  
*Reduce the risk of a flare-up or worsening of symptoms  
*Improve Quality of Life  
*Improve [[Quality of Life]]
*Offer longevity
*Offer longevity


Line 135: Line 109:
== Viewing  ==
== Viewing  ==
The below is a 12 minute video on HF
The below is a 12 minute video on HF
*https://youtu.be/2aiRpr5UCZs?list=PLbKSbFnKYVY2LhsYihIVUBpW6DJGMSSC4<br>
{{#ev:youtube|v=2aiRpr5UCZs&list=PLbKSbFnKYVY2LhsYihIVUBpW6DJGMSSC4}}<ref>reference</ref>  
 
== Resources ==
[https://www.racgp.org.au/getattachment/4342f9ab-e202-4f8e-b9aa-751ab2c45441/Exercise-based-rehabilitation-for-heart-failure.aspx Exercise based rehabilitation for heart failure]


== References  ==
== References  ==

Latest revision as of 06:47, 8 February 2023

Introduction[edit | edit source]

Heart failure.png

Heart failure is a syndrome of cardiac ventricular dysfunction, where the heart is unable to pump sufficiently to meet the body's blood flow requirements.

  • The symptoms come from an inadequate cardiac output, failing to keep up with the metabolic demands of the body.
  • It is a leading cause of cardiovascular morbidity and mortality worldwide despite the advances in therapies and prevention.
  • It can result from disorders of the pericardium, myocardium, endocardium, heart valves, great vessels, or some metabolic abnormalities.[1]

Heart failure is a major public health concern in countries worldwide. The increasing prevalence of heart failure in the population is most likely secondary to the aging of the population, increased risk factors, better outcomes for acute coronary syndrome survivors, and a reduction in mortality from other chronic conditions[2]. It is estimated that globally more than 25 million people are affected by HF.[3]

Epidemiology[edit | edit source]

Hf.png

Heart failure is a significant public health problem with a prevalence of over 5.8 to 6.5 million in the U.S. and around 26 million worldwide[4].

Multiple conditions can cause HF, including systemic diseases, a wide range of cardiac conditions, and some hereditary defects.

  • Etiologies of HF vary between high-income and developing countries, and patients may have mixed etiologies.
    • Coronary artery disease and chronic obstructive pulmonary disease (COPD) are the most common underlying causes of HF in high-income regions.
    • Conversely, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, and myocarditis are the primary conditions for HF in low-income regions, according to a systemic analysis for the Global Burden of Disease Study.
  • More than two-thirds of all cases of HF are attributable to ischemic heart disease, COPD, hypertensive heart disease, and rheumatic heart disease.[1]

Aetiology[edit | edit source]

There are multiple risk factors for heart failure, including older age (65 years or over), being male, having a family history of the condition, or having certain underlying conditions, particularly myocardial infarction , cardiac valve insufficiency (leaking) or stenosis (narrowing), and diabetes. Certain lifestyle factors—such as tobacco smoking, alcohol consumption, physical inactivity, and a diet that predisposes individuals to high cholesterol and high blood pressure—also raise the risk of developing heart failure[3]

Clinical presentation[edit | edit source]

Although it is useful to divide the signs and symptoms of heart failure according to the degree of left or right ventricular dysfunction, the heart is an integrated pump, and patients commonly present with both sets of signs and symptoms.

Left ventricular failure: Patients usually report fatigue, dyspnea on exertion, and if severe, at rest. Orthopnea, paroxysmal nocturnal dyspnea and Cheyne-Stokes respiration can also be a feature.

  • On examination tachypnea, dyspnea, tachycardia, hypotension and cyanosis may be observed. Palpation may reveal a laterally displaced apex beat while cardiac auscultation may elicit murmurs such as aortic stenosis or mitral regurgitation. Features of pulmonary edema eg inspiratory bibasal crackles not cleared on coughing, diminished breath sounds and dullness to percussion, may also be noted.

Right ventricular failure: Symptoms include ankle swelling, fatigue, abdominal bloating/discomfort and nocturia.

  • Evidence of right ventricular failure can manifest as peripheral edema (if severe extending to thighs and sacrum), ascites, hepatomegaly, elevated jugular venous pressure (JVP). JVP can be further accentuated by hepatojugular reflux. Cardiac murmurs may also be heard, commonly tricuspid regurgitation.

Clinical severity varies significantly and usually classified according to the New York Heart Association, which is graded according to how much physical activity is decreased[5].

Pathology[edit | edit source]

Fig-2-Changes-in-the-myocardium-during-aging-Heart-and-vasculature-undergo-alterations.png

Myocardial damage due to myocardial infarcts, cardiomyopathy and myocarditis can cause or aggravate heart failure.

Additionally, valvular disease such as aortic stenosis or mitral regurgitation may result in heart failure as well.

Further causes include conduction defects, cardiac arrhythmia and infiltrative/matrix disorders.

Systemic factors that may contribute or exacerbate heart failure include anemia, hyperthyroidism or hypertension[5].

See also Cardiovascular Considerations in the Older Patient

Management[edit | edit source]

Digoxin vial.jpg

Prognosis is usually poor unless the underlying cause is reversed. As a result, patients generally gradually deteriorate with episodes of acute decompensation and ultimately death.

In addition to treating the underlying cause of heart failure, management is directed at dietary and lifestyle changes, medications including ACE inhibitors or beta blockers and if appropriate, implantable cardioverter-defibrillator (ICD) or cardiac resynchronisation therapy (CRT).[5] Diuretics are prescribed to remove excess fluid. Digoxin and digitoxin are commonly prescribed to increase the strength of heart contraction[3].

Patients are also advised to limit their intake of salt and fluids, avoid alcohol and nicotine, optimize their body weight, and engage in aerobic exercise as much as possible. Much can be done to prevent and treat heart failure, but ultimately the prognosis depends on the underlying disease causing the difficulty as well as the severity of the condition at the time of presentation.

See also Pharmacological Management of Heart Failure

Physiotherapy[edit | edit source]

Exercise older person.jpg

Physiotherapy is important in the management of heart failure. The cornerstone of physiotherapy management is cardiac rehabilitation. In patients undergoing heart surgery, physiotherapy can also help with recovery after surgery.

Up until the late 1980s, exercise was considered unsafe for the patient with HF. It was unclear whether any benefit could be gained from rehabilitation, and concern also existed regarding patient safety, with the belief that additional myocardial stress would cause further harm. Since this time, considerable research has been completed and the evidence resoundingly suggests that exercise for this patient group is not only safe but also provides substantial physiological and psychological benefits. As such, exercise is now considered an integral component of the non pharmacological management of these patients

Aims of effective treatment for heart failure[edit | edit source]

  • Strengthen the heart
  • Improve symptoms
  • Reduce the risk of a flare-up or worsening of symptoms
  • Improve Quality of Life
  • Offer longevity

Recent research findings[edit | edit source]

  • Systematic review and meta-analysis show a significant effect of aerobic and resistance training on peak oxygen consumption, muscle strength, and health-related quality of life in patients with heart failure with a reduced left ventricular ejection fraction[6]
  • A study published in the Journal of Cardiopulmonary Rehabilitation and Prevention 2020, comparing the effects of β-blockers and non-β-blockers on Heart Rate (HR) and Oxygen Uptake (VO2) during exercise and recovery in older patients with heart failure with a preserved ejection fraction (HFpEF) demonstrated no significant differences in values (HRpeak, HRresv, HRrecov, or VO2) between both the groups, along with significant correlation between HRresv and VO2peak, suggesting the efficacy of these measures in prognostic and functional assessment and clinical applications, including the prescription of exercise, in elderly HFpEF patients[7].
  • Studies show a contrasting effect of aerobic training and resistance training on some echocardiographic parameters in patients with heart failure with reduced ejection fraction. While aerobic training was associated with evidence of worsening myocardial diastolic function, this was not apparent after resistance training. Further studies are indicated to investigate the long-term clinical significance of these adaptations[8].
  • А single-blind, prospective randomized controlled trial suggests: modified group-based High-intensity aerobic interval training (HIAIT) intervention showed more considerable improvement as compared to moderate-intensity continuous training (MICT) in the rehabilitation of patients with chronic heart failure (CHF). Physical and rehabilitation medicine (PRM) physicians should apply Group based Cardiac intervention in routine cardiac rehabilitation (CR) practice[9].
  • An article published online (March 2020) suggests positive outcomes with the High-intensity interval training (HIIT) for patients with heart failure along with preserved ejection fraction[10].
  • A study assessing patients carrying out 5-months cardiac rehabilitation CR showed a lower rate of clinical events with higher maximal inspiratory pressure, suggesting that the changes in respiratory muscle strength independently predicted the occurrence of clinical manifestations in patients with Heart Failure HF[11].
  • The results of a cross-sectional study in Spain by Raul Juarez-Vela et al. show that Heart Failure patients depend on others' care, especially for moving, dressing, personal hygiene, participating in daily and recreational activities, suggesting a weaker relationship between care dependency and the patients' physical deterioration[12].

Multidisciplinary team members[edit | edit source]

The other members of the MDT are vast but include

  • Surgeons and consultants - They operate if needed. Numerous operations are available and may be suitable for certain patients. For example, Heart Valve Surgery, Angioplasty or Bypass, Left Ventricular Assist Devices, Cardiac Inplant Electronic Devices, Heart Transplant. However, this is individual and would need to be discussed with the consultant in charge of the case.
  • Nutritionists - They work out a diet plan to suit the individual needs of the patient. As diet is a risk factor for CHD this is an extremely important member of the MDT for further prevention.
  • Counselor - As Heart failure is normally a lifelong condition the patient may have difficulty coming to terms with the impact this will have on their life. A counsellor will be available for sessions on coping with the disease.
  • Personal Trainer- As with a Physiotherapist will help to provide a more balanced lifestyle and improve fitness levels. This is something that will not only give the patient goals to work towards but also important social interaction with someone who is seen as less of a medical figure and therefore adds more normality to the individuals day to day life.
  • Family and Friends- This support network is an extremely important factor contributing to recover of a patient and should not be overlooked.

The list of people involved in this team is huge and is not exhaustive in this piece, however, Pharmacists, Social Groups, GP’s, Nurses and Podiatrists are all members of this MDT. Recovery cannot occur without input and communication from every member of the team.

Prevention[edit | edit source]

There are many factors that increase the risk of developing heart failure. And with some lifestyle changes and sometimes drug intervention this risk could be dramatically reduced. Hypertension and smoking are major risks for heart failure.

  • Stop smoking. Quitting smoking is noted as the single best way to reduce risk of heart failure. Smoking has many physiological effects forcing the heart to walk harder.
  • Reduce blood pressure. High blood pressure increases the work demand put on the heart to transport blood around the body, this increased work causes a hypertrophic reaction of the heart muscle, eventually leading to a weakened or stiff heart.
  • Reduce Cholesterol Level. High levels of cholesterol can cause furring and narrowing of the arteries termed atherosclerosis and eventually heart failure.
  • Lose weight. Being overweight increases demand placed on the heart and increases risk of heart failure and attack.
  • Eat a healthy diet. A healthy diet can help reduce your risk of developing coronary heart disease and therefore heart failure.
  • Keep active. Regular physical activity will help keep the heart healthy and also maintain a healthy weight.
  • Reduce Alcohol intake. Drinking excess of the recommended amount of alcohol per week can increase your blood pressure. Heavy drinking for long periods of time can cause damage to your heart muscle leading directly to heart failure.
  • Cut your salt intake. Excessive salt intake increases blood pressure and again, increases stress put on the heart.

Viewing[edit | edit source]

The below is a 12 minute video on HF

[13]

Resources[edit | edit source]

Exercise based rehabilitation for heart failure

References[edit | edit source]

  1. 1.0 1.1 Hajouli S, Ludhwani D. Heart failure and ejection fraction.Available: https://www.ncbi.nlm.nih.gov/books/NBK553115/(accessed 19.9.2021)
  2. King KC, Goldstein S. Congestive Heart Failure and Pulmonary Edema. StatPearls [Internet]. 2021 Jan 20.Available: https://www.statpearls.com/ArticleLibrary/viewarticle/19880(accessed 2.6.2021)
  3. 3.0 3.1 3.2 Britannica Heart Failure Available: https://www.britannica.com/science/heart-failure(accessed 1.6.2021)
  4. Hajouli S, Ludhwani D. Heart Failure And Ejection Fraction 2020.Available from:https://www.ncbi.nlm.nih.gov/books/NBK553115/ (last accessed 11.8.2020)
  5. 5.0 5.1 5.2 Radiopedia heart failure Available: https://radiopaedia.org/articles/heart-failure-summary?lang=us(accessed 19.9.2021)
  6. Neto MG, Durães AR, Conceição LS, Roever L, Silva CM, Alves IG, Ellingsen Ø, Carvalho VO. Effect of combined aerobic and resistance training on peak oxygen consumption, muscle strength and health-related quality of life in patients with heart failure with reduced left ventricular ejection fraction: a systematic review and meta-analysis. International Journal of Cardiology. 2019 Jun 24.
  7. Maldonado-Martín S, Brubaker PH, Ozemek C, Jayo-Montoya JA, Becton JT, Kitzman DW. Impact of β-Blockers on Heart Rate and Oxygen Uptake During Exercise and Recovery in Older Patients With Heart Failure With Preserved Ejection Fraction. Journal of Cardiopulmonary Rehabilitation and Prevention. 2020 Jan 2.
  8. Lan NS, Lam K, Naylor LH, Green DJ, Minaee NS, Dias P, Maiorana AJ. The Impact of Distinct Exercise Training Modalities on Echocardiographic Measurements in Patients with Heart Failure with Reduced Ejection Fraction. Journal of the American Society of Echocardiography. 2019 Dec 4.
  9. MEDICA EM. Group-based cardiac rehabilitation interventions. A challenge for physical and rehabilitation medicine physicians: a randomized controlled trial. European Journal of Physical and Rehabilitation Medicine. 2020 Jan 23.
  10. Paul J Beckers, Andreas B Gevaert High intensity interval training for heart failure with preserved ejection fraction: High hopes for intense exercise European Journal of Preventive Cardiology 0(00) 1–3 The European S Article reuse guidelines: sagepub.com/journals-permissions DOI: 10.1177/2047487320910294 journals.sagepub.com/home/cpr
  11. Hamazaki N, Kamiya K, Yamamoto S, Nozaki K, Ichikawa T, Matsuzawa R, Tanaka S, Nakamura T, Yamashita M, Maekawa E, Meguro K. Changes in Respiratory Muscle Strength Following Cardiac Rehabilitation for Prognosis in Patients with Heart Failure. Journal of Clinical Medicine. 2020 Apr;9(4):952.
  12. Juárez-Vela R, Durante Á, Pellicer-García B, Cardoso-Muñoz A, Criado-Gutiérrez JM, Antón-Solanas I, Gea-Caballero V. Care Dependency in Patients with Heart Failure: A Cross-Sectional Study in Spain. International Journal of Environmental Research and Public Health. 2020 Jan;17(19):7042.
  13. reference